An antiviral widely used to treat hospitalized patients did not lower the mortality rate in a multinational trial.
Source: New York Times
Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial
Published in Coronavirus (2019-nCoV), Deaths (Fatalities), Drugs (Pharmaceuticals), Gilead Sciences Inc, Remdesivir (Drug), United States, World Health Organization and your-feed-science
More from Coronavirus (2019-nCoV)More posts in Coronavirus (2019-nCoV) »
More from Deaths (Fatalities)More posts in Deaths (Fatalities) »
- Disney Backs Down From Effort to Use Disney+ Agreement to Block Lawsuit
- Police Fatally Shoot Queens Man Who Brandished Scissors, Officials Say
- Coast Guard Works to Keep Burning Ship From Capsizing at New Jersey Port
- New Covid Booster Shots Cut Risk of Hospitalization by Half, CDC Reports
- Covid May Spread From Corpses, Scientists Report
More from Drugs (Pharmaceuticals)More posts in Drugs (Pharmaceuticals) »
More from Remdesivir (Drug)More posts in Remdesivir (Drug) »
More from United StatesMore posts in United States »
- New Covid Booster Shots Cut Risk of Hospitalization by Half, CDC Reports
- Long Covid Has Played Role in More Than 3,500 Deaths in US, CDC Says
- Hometown of Tyler Adams, U.S. Captain, Still Proud Even With Loss
- Judge Criticizes D.A. for Halting Prosecution of Woman in Husband’s Death
- New York Philharmonic Was Once All-Male. Now, Women Outnumber Men.
More from World Health OrganizationMore posts in World Health Organization »
More from your-feed-scienceMore posts in your-feed-science »
- Covid May Spread From Corpses, Scientists Report
- Grant Wahl Died of a Burst Blood Vessel, His Family Says
- Long Covid Has Played Role in More Than 3,500 Deaths in US, CDC Says
- Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
- As the Pandemic Drags On, Americans Struggle for New Balance
Be First to Comment